ARS Pharmaceuticals Statistics
NASDAQ: SPRYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.96-0.40 (-11.90%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ARS Pharmaceuticals by the numbers
ARS Pharmaceuticals has a market capitalization of $297.6 million based on 100.53M shares outstanding. With trailing EPS of $-2.01, ARS Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.1% below its 50-day average and 56.9% below its 200-day average.
Average daily trading volume is 1.83M shares, or about $5.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SPRY valuation vs. peer median
| Metric | SPRY | Peer median | Difference |
|---|---|---|---|
| Market cap | $297.56M | $284.22M | +5% |
| Avg. volume | 1.83M | 566.12K | +223% |
Peer median across 8 companies: EVMN, BNTC, GLSI, FULC, RLMD, AVIR, GALT, LRMR.
Valuation
- Market cap
- $297.56M
- Price / sales (latest FY)
- 3.53
- EPS (TTM)
- $-2.01
- Shares outstanding
- 100.53M
Price and trading
- Previous close
- 3.36
- Open
- 3.28
- Day range
- 2.86 – 3.47
- 52-week range
- 2.44 – 13.15
- 52-week change
- -61.00%
- Beta
- —
- Volume
- 2.78M
- Average volume
- 1.83M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 297.56M
- Forward Pe
- -3.60
- Eps
- -2.01
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.15
- Week52 Low
- 2.44
- Avg Volume
- 1.83M
- Shares Outstanding
- 100.53M
- Ma50
- 3.90
- Ma200
- 6.87
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -77.49%
- Pct From52w Low
- 21.31%